- Home
- NVVE vs BDRX Comparison
NVVE vs BDRX Comparison
Compare NVVE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVE | BDRX |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United Kingdom |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | NVVE | BDRX |
|---|---|---|
| Price | $0.88 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 201.1K | 116.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $892.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.10 | $0.79 |
| 52 Week High | $5.69 | $11.88 |
Technical Indicators
Market Signals| Indicator | NVVE | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 31.28 |
| Support Level | $0.83 | $0.79 |
| Resistance Level | $1.13 | $1.29 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 14.16 | 12.18 |
Price Performance
Historical ComparisonAbout NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.